Pharmagreen Biotech (Pharmagreen Biotech) Total Liabilities : $2.29 Mil (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Total Liabilities?

Pharmagreen Biotech's Total Liabilities for the quarter that ended in Jun. 2023 was $2.29 Mil.

Pharmagreen Biotech's quarterly Total Liabilities increased from Dec. 2022 ($2.01 Mil) to Mar. 2023 ($2.15 Mil) and increased from Mar. 2023 ($2.15 Mil) to Jun. 2023 ($2.29 Mil).

Pharmagreen Biotech's annual Total Liabilities declined from Sep. 2020 ($3.20 Mil) to Sep. 2021 ($2.07 Mil) and declined from Sep. 2021 ($2.07 Mil) to Sep. 2022 ($2.03 Mil).

Pharmagreen Biotech Total Liabilities Historical Data

The historical data trend for Pharmagreen Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Total Liabilities Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

Total Liabilities

Get a 7-Day Free Trial

1.84

1.47

3.20

2.07

2.03

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Liabilities	Get a 7-Day Free Trial															2.13	2.03	2.01	2.15	2.29

Pharmagreen Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pharmagreen Biotech's Total Liabilities for the fiscal year that ended in Sep. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.912	+	(0.119	+	0.0010000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.03

Total Liabilities	=	Total Assets (A: Sep. 2022 )	-	Total Equity (A: Sep. 2022 )
	=	0.209	-	-1.823
	=	2.03

Pharmagreen Biotech's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.172	+	(0.12	+	-0.0010000000000002
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.29

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	0.14	-	-2.151
	=	2.29

Pharmagreen Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.